(Q44154656)

30 November 2017

title

New 3-benzisothiazolyl and 3-benzisoxazolylpiperazine derivatives with atypical antipsychotic binding profile (English)

1 reference

30 November 2017

Aurelio Orjales

1

1 reference

30 November 2017

Ramón Mosquera

2

1 reference

30 November 2017

Antonio Toledo

3

1 reference

30 November 2017

Carmen Pumar

4

1 reference

30 November 2017

Luis Labeaga

5

1 reference

30 November 2017

Ana Innerárity

6

1 reference

30 November 2017

publication date

1 September 2002

1 reference

European Journal of Medicinal Chemistry

30 November 2017

published in

1 reference

30 November 2017

volume

37

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

721-730

1 reference

Atypical antipsychotics--recent findings and new perspectives

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901391-0

7 January 2021

Clozapine: a novel antipsychotic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901391-0

7 January 2021

CLOZAPINE AND AGRANULOCYTOSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901391-0

7 January 2021

Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901391-0

7 January 2021

3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901391-0

7 January 2021

Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901391-0

7 January 2021

Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901391-0

7 January 2021

Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901391-0

7 January 2021

3,4-dihydro-2(1H)-quinazolinones

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901391-0

7 January 2021

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901391-0

7 January 2021

Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901391-0

7 January 2021

A practical computer-based approach to the analysis of radioligand binding experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901391-0

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901391-0

7 January 2021

10.1016/S0223-5234(02)01391-0

Identifiers

DOI

1 reference

30 November 2017

1 reference